Comprehensive Company Analysis Tracks the Major M&A Trends and Developments within Dr Reddy's Laboratories Limited.DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c76919) has announced the addition of "Company Analysis - Dr. Reddy's Laboratories Dr. Reddy’s Laboratories Ltd. (Reddy's), founded in 1984 by Dr. K. Anji Reddy, has become India’s third biggest pharmaceutical company. Reddy had worked in the publicly-owned Indian Drugs and Pharmaceuticals Ltd. Limited" to their offering. Company Analysis assists individual investors, managers and companies in evaluating opportunities, trends, market innovations as well as in selecting appropriate information solutions in order to make effective investment decisions. The study covers information on the business structure, areas of operation, products and services offered by the company. It comprises SWOT analysis SWOT Analysis A tool that identifies the strengths, weaknesses, opportunities and threats of an organization. , Key Ratios, and financials that aid investors in gaining an insight into the company's performance. The report is based on extensive research using data available from credible publications, trade journals, industry associations and the company sources. Report Highlights - Provides a comprehensive version of the company's performance - Offers key financial data, ratio and SWOT analysis - Tracks major M&A trends and developments - Business Profile, SWOT analysis and financial information on top five competitors - View on the company by our analysts - Supplemented with graphs and tabular tab·u·lar adj. 1. Having a plane surface; flat. 2. Organized as a table or list. 3. Calculated by means of a table. tabular resembling a table. information wherever necessary Contents: 1. Company Overview 1.1 History 1.2 Business Overview 1.3 Organizational Structure  This article has no lead section.To comply with Wikipedia's lead section guidelines, one should be written. 1.4 Ticker ticker An automated quotation system on which security transactions are reported after they occur on an exchange floor. Even though the newer systems are electronic and no longer actually tick, the name of the old mechanical device has stuck. Codes at various Stock Exchange Listings 1.5 Major Mergers & Acquisitions 1.6 Management Profile 2. Product & Services 2.1 Product & Services - An Overview 2.2 Revenue & Income Summary by Business Segment 2.3 Revenue & Income Summary by Geographical Distribution the natural arrangements of animals and plants in particular regions or districts. See under Distribution. See also: Distribution Geographic 3. Financial Information for the Fiscal Year 3.1 Financial Summary for the Fiscal Year 3.2 Breakup breakup The division of a company into separate parts. The most famous breakup to date was the 1984 division of AT&T (formerly, American Telephone & Telegraph Company). This breakup was intended to increase competition in the communications industry. of Revenue & Sales Trends 3.3 Ratio & Market Indicators 3.4 Earning & Income Estimates 4. SWOT Analysis 4.1 Strength 4.2 Weaknesses 4.3 Opportunity 4.4 Threats 5. Top Competitors 5.1 Ranbaxy Laboratories Ranbaxy Laboratories Limited is an Indian company incorporated in 1961. It is India's largest pharmaceutical company. It exports its products to 125 countries with ground operations in 46 and manufacturing facilities in seven countries. Limited 5.2 Cipla Limited 5.3 Nicholas Piramal This article or section has multiple issues: * Its neutrality is disputed. * It needs sources or references that appear in third-party publications. * It reads like an advertisement and needs to be rewritten in a neutral point of view. India Limited 5.4 Sun Pharmaceuticals Industries Ltd. 5.5 Zydus Cadila Healthcare Cadila Healthcare is an Indian pharmaceutical company headquartered at Ahmedabad in Gujarat state of western India. The company is the fifth largest pharmaceutical company in India, with US$290m in turnover in 2004. It is a significant manufacturer of generic drugs. Limited 6. Analyst View List of Tables Table 1 1: Dr. Reddy's Laboratories Limited - Ticker Codes at various Stock Exchanges Table 1 2: Dr. Reddy's Laboratories Limited - Major Mergers & Acquisitions (1999 to 2007) Table 1 3: Dr. Reddy's Laboratories Limited - Key Management People Table 3 1: Dr. Reddy's Laboratories Limited - Financial Overview (in Million Rs), March 2007 Table 3 2: Dr. Reddy's Laboratories Limited - Breakup of Revenue & Sales (in Million Rs), March 2005 to March 2007 Table 3 3: Dr. Reddy's Laboratories Limited - Key Financial Ratios (March 2005 to March 2007) Table 3 4: Dr. Reddy's Laboratories Limited - Consolidated Earning & Income Estimates (in Million Rs), March 2005 to March 2007 Table 5 1: Ranbaxy Laboratories Limited - Key Financials (in Million INR INR In currencies, this is the abbreviation for the Indian Rupee. Notes: The currency market, also known as the Foreign Exchange market, is the largest financial market in the world, with a daily average volume of over US $1 trillion. ), 2004-2006 Table 5 2: Ranbaxy Laboratories Limited - SWOT Analysis Table 5 3: Cipla Limited - Key Financials (in Rs Crore n. 1. Ten millions; as, a crore of rupees (which is nearly $5,000,000) s>. Noun 1. crore - the number that is represented as a one followed by 7 zeros; ten million ), 2005-06 & 2006-07 Table 5 4: Cipla Limited - SWOT Analysis Table 5 5: Nicholas Piramal India Limited - Key Financials (in Million INR), 2005-06 & 2006-07 Table 5 6: Nicholas Piramal India Limited - SWOT Analysis Table 5 7: Sun Pharmaceuticals Industries Ltd. - Key Financials (in Million INR), 2005-06 & 2006-07 Table 5 8: Sun Pharmaceuticals Industries Ltd. - SWOT Analysis Table 5 9: Zydus Cadila Healthcare Limited - Key Financials (in Million INR), March 2004 to March 2006 Table 5 10: Zydus Cadila Healthcare Limited - SWOT Analysis List of Figures Figure 2 1: Dr. Reddy's Laboratories Limited - Gross Revenue by Business Segment (in Million Rs), March 2006 & March 2007 Figure 2 2: Dr. Reddy's Laboratories Limited - Gross Revenue by Geographical Distribution (in Million Rs), March 2006 & March 2007 For more information visit http://www.researchandmarkets.com/reports/c76919 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion